NCT00490360View on ClinicalTrials.gov

Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head

PHASE2CompletedINTERVENTIONAL
Enrollment

2,007

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

May 31, 2007

Conditions
Cancer of the Pancreatic Head
Interventions
DRUG

Gemcitabine / Cisplatin

Trial Locations (1)

Unknown

University Hospital of Zurich, Department of Surgery, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT00490360 - Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head | Biotech Hunter | Biotech Hunter